Result of General Meeting

Provided By GlobeNewswire

Last update: May 2, 2025

May 2, 2025

Biodexa Pharmaceuticals PLC
(“Biodexa” or the “Company”)

Result of General Meeting

Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces that at its General Meeting held at 1.00pm BST today, ordinary resolutions 1 and 2 were passed by majorities of 62% and 61%, respectively. Special resolution 3 failed to pass with a majority vote of 71%. Because resolution 1 was contingent on the passing of resolution 3, resolution 1 also failed to pass.